Oral fluoropyrimidines in colorectal cancer

Tislelizumab plus chemotherapy for advanced or metastatic esophageal squamous-cell carcinoma in patients with PD-L1 Tumor Area Positivity score ≥5%: a post hoc, exploratory, long-term follow-up of RATIONALE-306☆.

ESMO open·2026

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

ESMO gastrointestinal oncology·2026

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

ESMO open·2026

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.

ESMO open·2026

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

ESMO gastrointestinal oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Seminars in oncology·2026

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Seminars in oncology·2026

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Seminars in oncology·2026

Malformin A1 Enhances 5-Fluorouracil-induced Apoptosis, Cell Cycle Arrest, and Anti-angiogenesis in Colorectal Cancer Cells.

Anticancer research·2026

Spectroscopic Signature of Apoptosis Induced by Venetoclax in Philadelphia-Positive Acute Lymphoblastic Leukemia.

Analytical chemistry·2026

Urgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report.

Cureus·2026

A comparative network analysis to explore cancer patient experiences with cannabis.

Frontiers in psychiatry·2026

An enantioselective covalent inhibitor of BAX confers cytoprotection in vivo.

Nature chemical biology·2026

Ramelteon Mitigates Cisplatin-induced Testicular Dysfunction in Rats.

In vivo (Athens, Greece)·2026

Related Experiment Videos

Oral fluoropyrimidines in colorectal cancer

Related Concept Videos

Tislelizumab plus chemotherapy for advanced or metastatic esophageal squamous-cell carcinoma in patients with PD-L1 Tumor Area Positivity score ≥5%: a post hoc, exploratory, long-term follow-up of RATIONALE-306☆.

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Malformin A1 Enhances 5-Fluorouracil-induced Apoptosis, Cell Cycle Arrest, and Anti-angiogenesis in Colorectal Cancer Cells.

Spectroscopic Signature of Apoptosis Induced by Venetoclax in Philadelphia-Positive Acute Lymphoblastic Leukemia.

Urgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report.

A comparative network analysis to explore cancer patient experiences with cannabis.

An enantioselective covalent inhibitor of BAX confers cytoprotection in vivo.

Ramelteon Mitigates Cisplatin-induced Testicular Dysfunction in Rats.

Related Experiment Videos

Oral fluoropyrimidines in colorectal cancer

Related Concept Videos

Related Articles